US Stocks
/
Protara Therapeutics, Inc. Share Price
Protara Therapeutics, Inc. Share Price

Protara Therapeutics, Inc. Share Price

NASDAQ: TARA | Micro Cap
$2.65
+$0.04 (1.73%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Protara Therapeutics, Inc. Stock Performance

Open
$2.59
Prev. Close
$2.60
Circuit Range
N/A
Day Range
$2.52 - $2.69
Year Range
$2.52 - $7.81
Volume
49,326
Average Traded
$2.61

Protara Therapeutics, Inc. Share Price Today

As of 9 October 2026, Protara Therapeutics, Inc.'s share price is $2.65. The stock opened at $2.59, compared to its previous close of $2.60. During today's trading session, Protara Therapeutics, Inc.'s share price traded between $2.52 and $2.69, with an average price of $2.60. Over the past 52 weeks, the stock has recorded a high of $7.81 and a low of $2.52. In terms of performance, Protara Therapeutics, Inc.'s share price has declined by 50.28% over the last six months and is down 48.84% on a year-on-year basis.

Protara Therapeutics, Inc. Share Price Chart

$2.52$2.69
L
Show Current Price
H

Protara Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$113.52M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.18
Revenue (TTM)
$0.00
Return On Equity (TTM)
-43.40%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-63.42%

Protara Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.26-$17.31-$17.78-$21.67
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-30.54%-2.72%-21.88%

Protara Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$65.95-$40.42-$44.60-$57.44
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A38.71%-10.34%-28.79%

About Protara Therapeutics, Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Protara Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.06
$2.65
-13.38%
Sep 2026
$3.83
$3.06
-23.28%
Aug 2026
$3.89
$4.00
+1.91%
Jul 2026
$3.88
$3.92
+2.75%
Jun 2026
$4.63
$3.81
-18.13%
May 2026
$5.38
$4.66
-12.57%
Apr 2026
$5.25
$5.33
+2.50%
Mar 2026
$6.28
$5.20
-18.37%
Feb 2026
$7.05
$6.37
-10.16%
Jan 2026
$5.30
$7.09
+33.27%
Dec 2025
$7.25
$5.32
-27.86%
Nov 2025
$5.26
$7.38
+42.37%

TARA Share Price FAQs

What is Protara Therapeutics, Inc. share price today?

chevron-up
Protara Therapeutics, Inc. share price today is $2.65 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Protara Therapeutics, Inc. stock?

chevron-up
The 52 week high of Protara Therapeutics, Inc. stock is $7.81, while the 52 week low is $2.52 as of 9 Oct '26.

What is TARA's market capitalisation today?

chevron-up
TARA market capitalisation is $113.52M as of October 9, 2026, at 11:45 am IST.

What is TARA's net income for the last quarter?

chevron-up
TARA's net income for the last quarter is -21.67B USD.

What is the 5 year returns of TARA?

chevron-up
The 5 year returns of TARA is -61.71% as on 9 Oct '26.

What is the high & low stock price of TARA today?

chevron-up
TARA stock price hit a high of $2.69 and low of $2.52 as of 9 Oct '26.

Can I buy TARA shares in India?

chevron-up
Yes. You can buy TARA in India by opening an international trading account.